000919 金陵药业
交易中 12-26 14:39:03
资讯
新帖
简况
金陵药业：截至2025年12月19日股东人数为37,395
证券之星 · 12-22
金陵药业：截至2025年12月19日股东人数为37,395
金陵药业（000919）披露南京梅山医院投资改扩建项目获股东会通过，12月18日股价上涨6.35%
证券之星 · 12-18
金陵药业（000919）披露南京梅山医院投资改扩建项目获股东会通过，12月18日股价上涨6.35%
金陵药业：截至2025年12月10日股东人数为32,789
证券之星 · 12-12
金陵药业：截至2025年12月10日股东人数为32,789
金陵药业：截至2025年11月28日股东人数为32,882
证券之星 · 12-01
金陵药业：截至2025年11月28日股东人数为32,882
金陵药业将清算注销全资子公司邦健天峰
中金财经 · 11-29
金陵药业将清算注销全资子公司邦健天峰
金陵药业最新公告：拟投资8.93亿元实施医院改扩建项目
证券之星 · 11-28
金陵药业最新公告：拟投资8.93亿元实施医院改扩建项目
金陵药业：公司将依法履行信息披露义务
证券日报 · 11-26
金陵药业：公司将依法履行信息披露义务
金陵药业(000919)11月20日股东户数3.29万户，较上期减少1.58%
证券之星 · 11-21
金陵药业(000919)11月20日股东户数3.29万户，较上期减少1.58%
金陵药业：截至11月10日股东户数为33417户
证券日报网 · 11-17
金陵药业：截至11月10日股东户数为33417户
金陵药业：截至2025年11月10日股东人数为33,417
证券之星 · 11-12
金陵药业：截至2025年11月10日股东人数为33,417
股市必读：金陵药业（000919）11月5日董秘有最新回复
证券之星 · 11-06
股市必读：金陵药业（000919）11月5日董秘有最新回复
股市必读：金陵药业（000919）10月31日董秘有最新回复
证券之星 · 11-03
股市必读：金陵药业（000919）10月31日董秘有最新回复
股市必读：金陵药业三季报 - 第三季度单季净利润同比下降1.84%
中金财经 · 10-29
股市必读：金陵药业三季报 - 第三季度单季净利润同比下降1.84%
金陵药业(000919)10月20日股东户数3.5万户，较上期增加0.79%
证券之星 · 10-28
金陵药业(000919)10月20日股东户数3.5万户，较上期增加0.79%
图解金陵药业三季报：第三季度单季净利润同比下降1.84%
证券之星 · 10-28
图解金陵药业三季报：第三季度单季净利润同比下降1.84%
金陵药业最新公告：与南京鼓楼医院签署7850万元技术转让合同
证券之星 · 10-27
金陵药业最新公告：与南京鼓楼医院签署7850万元技术转让合同
金陵药业（000919）披露向特定对象发行股票部分限售股份解除限售上市流通提示性公告，10月23日股价上涨0.14%
证券之星 · 10-23
金陵药业（000919）披露向特定对象发行股票部分限售股份解除限售上市流通提示性公告，10月23日股价上涨0.14%
金陵药业：截至2025年10月20日股东人数为35,009
证券之星 · 10-21
金陵药业：截至2025年10月20日股东人数为35,009
金陵药业（000919）披露限制性股票回购注销完成公告，10月16日股价上涨0.14%
证券之星 · 10-16
金陵药业（000919）披露限制性股票回购注销完成公告，10月16日股价上涨0.14%
金陵药业：截至2025年10月10日股东人数为34,733
证券之星 · 10-14
金陵药业：截至2025年10月10日股东人数为34,733
加载更多
公司概况
公司名称：
金陵药业股份有限公司
所属行业：
医药制造业
上市日期：
1999-11-18
主营业务：
金陵药业股份有限公司的主营业务是药品、医疗器械制造和医康养护服务。公司的主要产品是脉络宁注射液/口服液、琥珀酸亚铁片、香菇多糖注射液、吸收性明胶海绵等。“桂冠”商标为中国驰名商标，“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品，“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。
发行价格：
8.40
{"stockData":{"symbol":"000919","market":"SZ","secType":"STK","nameCN":"金陵药业","latestPrice":7.7,"timestamp":1766731143000,"preClose":7.5,"halted":0,"volume":25166201,"delay":0,"changeRate":0.0267,"floatShares":622000000,"shares":622000000,"eps":0.0603,"marketStatus":"交易中","change":0.2,"latestTime":"12-26 14:39:03","open":7.51,"high":7.86,"low":7.48,"amount":194000000,"amplitude":0.0507,"askPrice":7.71,"askSize":333,"bidPrice":7.7,"bidSize":519,"shortable":0,"etf":0,"ttmEps":0.0603,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766732400000},"marketStatusCode":2,"adr":0,"adjPreClose":7.5,"symbolType":"stock","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":8.25,"lowLimit":6.75,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":621924528,"isCdr":false,"pbRate":1.23,"roa":"--","peRate":127.694859,"roe":"1.8%","epsLYR":0.0682,"committee":-0.194132,"marketValue":4789000000,"turnoverRate":0.0405,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-29。","floatMarketCap":4788000000},"requestUrl":"/m/hq/s/000919","defaultTab":"news","newsList":[{"id":"2593910065","title":"金陵药业：截至2025年12月19日股东人数为37,395","url":"https://stock-news.laohu8.com/highlight/detail?id=2593910065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593910065?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:25","pubTimestamp":1766391911,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截止到12.20日的股东人数是多少?谢谢！金陵药业回复：投资者，您好！截至2025年12月19日，公司股东人数为37,395，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200016721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0239","000919"],"gpt_icon":0},{"id":"2592904786","title":"金陵药业（000919）披露南京梅山医院投资改扩建项目获股东会通过，12月18日股价上涨6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904786","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592904786?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:23","pubTimestamp":1766067818,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，金陵药业报收于7.37元，较前一交易日上涨6.35%，最新总市值为45.84亿元。该股当日开盘6.91元，最高7.43元，最低6.91元，成交额达2.04亿元，换手率为4.54%。公司近日发布公告称，于2025年12月18日召开第四次临时股东会，审议通过关于南京梅山医院投资改扩建项目的议案。会议采用现场与网络投票结合方式，出席股东211人，代表股份占公司有表决权股份总数的43.9370%。议案获总同意票占比99.4905%，中小股东同意票占比89.9585%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800038734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0239","BK0096","BK0028"],"gpt_icon":0},{"id":"2590652172","title":"金陵药业：截至2025年12月10日股东人数为32,789","url":"https://stock-news.laohu8.com/highlight/detail?id=2590652172","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590652172?lang=zh_cn&edition=full","pubTime":"2025-12-12 11:36","pubTimestamp":1765510596,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)12月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年12月10日A股股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2025年12月10日，公司股东人数为32,789，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200013682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0239","BK0028","BK0096"],"gpt_icon":0},{"id":"2588741021","title":"金陵药业：截至2025年11月28日股东人数为32,882","url":"https://stock-news.laohu8.com/highlight/detail?id=2588741021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588741021?lang=zh_cn&edition=full","pubTime":"2025-12-01 15:12","pubTimestamp":1764573125,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年11月28日A股股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2025年11月28日，公司股东人数为32,882，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100012303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0028","BK0239"],"gpt_icon":0},{"id":"2587680750","title":"金陵药业将清算注销全资子公司邦健天峰","url":"https://stock-news.laohu8.com/highlight/detail?id=2587680750","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587680750?lang=zh_cn&edition=full","pubTime":"2025-11-29 17:31","pubTimestamp":1764408662,"startTime":"0","endTime":"0","summary":"中访网数据 金陵药业股份有限公司于2025年11月28日召开第九届董事会第二十二次会议，审议通过了关于清算注销其全资子公司湖州邦健天峰药业有限公司的议案。根据审计报告，截至2024年12月31日，该公司总资产为314.86万元，净资产为307.57万元，2024年度营业收入为44.54万元，净利润为0.39万元。公司表示，此次清算不会对公司当期及未来财务状况和经营成果产生重大影响，清算完成后邦健天峰将不再纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251129/31833743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000919","BK0028","BK0096","BK0239"],"gpt_icon":0},{"id":"2586781061","title":"金陵药业最新公告：拟投资8.93亿元实施医院改扩建项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2586781061","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586781061?lang=zh_cn&edition=full","pubTime":"2025-11-28 20:00","pubTimestamp":1764331213,"startTime":"0","endTime":"0","summary":"金陵药业(000919.SZ)公告称，控股子公司南京梅山医院为更好地满足辐射区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与服务能力，拟投资8.93亿元实施医院改扩建项目。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800033934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0239","BK0096"],"gpt_icon":0},{"id":"2586252023","title":"金陵药业：公司将依法履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2586252023","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586252023?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:40","pubTimestamp":1764160800,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n郑重声明：东方财富发布此内容旨在传播更多信息，与本站立场无关，不构成投资建议。据此操作，风险自担。 \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-26/doc-infytuqz1658552.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-26/doc-infytuqz1658552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","000919","BK0028","BK0096"],"gpt_icon":0},{"id":"2585111147","title":"金陵药业(000919)11月20日股东户数3.29万户，较上期减少1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585111147","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585111147?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:14","pubTimestamp":1763720045,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2025年11月20日公司股东户数为3.29万户，较11月10日减少527.0户，减幅为1.58%。在化学制药行业个股中，金陵药业股东户数低于行业平均水平，截至11月20日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年11月10日至2025年11月20日，金陵药业区间跌幅为2.04%，在此期间股东户数减少527.0户，减幅为1.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100028554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","000919"],"gpt_icon":0},{"id":"2584475776","title":"金陵药业：截至11月10日股东户数为33417户","url":"https://stock-news.laohu8.com/highlight/detail?id=2584475776","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584475776?lang=zh_cn&edition=full","pubTime":"2025-11-17 18:38","pubTimestamp":1763375880,"startTime":"0","endTime":"0","summary":"证券日报网讯金陵药业11月17日在互动平台回答投资者提问时表示，截至2025年11月10日，公司股东人数为33417户。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-17/doc-infxtkpy4786902.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-17/doc-infxtkpy4786902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0096","BK0239","000919","BK0028"],"gpt_icon":0},{"id":"2582731171","title":"金陵药业：截至2025年11月10日股东人数为33,417","url":"https://stock-news.laohu8.com/highlight/detail?id=2582731171","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582731171?lang=zh_cn&edition=full","pubTime":"2025-11-12 09:00","pubTimestamp":1762909252,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年11月10日A股股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2025年11月10日，公司股东人数为33,417，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200006252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0096","BK0028"],"gpt_icon":0},{"id":"2581708778","title":"股市必读：金陵药业（000919）11月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2581708778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581708778?lang=zh_cn&edition=full","pubTime":"2025-11-06 02:33","pubTimestamp":1762367593,"startTime":"0","endTime":"0","summary":"截至2025年11月5日收盘，金陵药业报收于7.28元，上涨0.55%，换手率1.37%，成交量8.51万手，成交额6181.38万元。董秘最新回复投资者： 请问金陵药业2025年前三季度净利润是否已经高于2024年全年净利润50%？当日关注点来自交易信息汇总：11月5日主力资金净流出410.07万元，显示主力短期谨慎态度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600001449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"gpt_icon":0},{"id":"2580232020","title":"股市必读：金陵药业（000919）10月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2580232020","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580232020?lang=zh_cn&edition=full","pubTime":"2025-11-03 07:36","pubTimestamp":1762126575,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，金陵药业报收于7.15元，上涨1.27%，换手率1.58%，成交量9.82万手，成交额6983.95万元。董秘最新回复投资者： 请问金陵药业证券部的人都在忙什么？而别的公司公布业绩后都有一大堆媒体进行正面解读引导！公司将会依法进行信息披露，请关注公司发布的公告和定期报告，谢谢！。当日关注点来自交易信息汇总：10月31日主力资金净流出264.99万元，占总成交额3.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300001701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0239","BK0028"],"gpt_icon":0},{"id":"2579914260","title":"股市必读：金陵药业三季报 - 第三季度单季净利润同比下降1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579914260","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579914260?lang=zh_cn&edition=full","pubTime":"2025-10-29 08:10","pubTimestamp":1761696610,"startTime":"0","endTime":"0","summary":"股东户数变动截至2025年10月20日，金陵药业股东户数为3.5万户，较10月10日增加276.0户，增幅0.79%；户均持股数量由上期的1.8万股减少至1.78万股，户均持股市值为12.45万元。财务报告金陵药业2025年三季报显示，公司主营收入23.8亿元，同比下降5.95%；归母净利润6845.83万元，同比下降10.81%；扣非净利润5664.42万元，同比上升24.09%。2025年第三季度单季度主营收入7.79亿元，同比下降4.53%；单季度归母净利润2012.48万元，同比下降1.84%；单季度扣非净利润2113.41万元，同比上升5377.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251029/31745733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000919"],"gpt_icon":0},{"id":"2578362019","title":"金陵药业(000919)10月20日股东户数3.5万户，较上期增加0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578362019","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578362019?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:28","pubTimestamp":1761643686,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2025年10月20日公司股东户数为3.5万户，较10月10日增加276.0户，增幅为0.79%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年10月10日至2025年10月20日，金陵药业区间涨幅为1.45%，在此期间股东户数增加276.0户，增幅为0.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","000919"],"gpt_icon":0},{"id":"2578624080","title":"图解金陵药业三季报：第三季度单季净利润同比下降1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578624080","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578624080?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:14","pubTimestamp":1761588876,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业2025年三季报显示，公司主营收入23.8亿元，同比下降5.95%；归母净利润6845.83万元，同比下降10.81%；扣非净利润5664.42万元，同比上升24.09%；其中2025年第三季度，公司单季度主营收入7.79亿元，同比下降4.53%；单季度归母净利润2012.48万元，同比下降1.84%；单季度扣非净利润2113.41万元，同比上升5377.48%；负债率19.54%，投资收益1352.12万元，财务费用-698.01万元，毛利率20.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800001924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919"],"gpt_icon":0},{"id":"2578610740","title":"金陵药业最新公告：与南京鼓楼医院签署7850万元技术转让合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2578610740","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578610740?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:13","pubTimestamp":1761563614,"startTime":"0","endTime":"0","summary":"金陵药业(000919.SZ)公告称，公司与南京鼓楼医院签署技术转让（技术秘密）合同，鼓楼医院将NK细胞特异抗原CD16a与肿瘤特异抗原细胞衔接器相关技术转让给公司，公司将进行后续开发、生产和销售。合同总金额7,850万元，公司将在合同生效后支付入门费150万元，其余款项分阶段支付。该交易有利于公司布局生物医药领域，拓展生物创新药管线，但对当期财务状况和经营业绩无重大影响，项目未来进展存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700029666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0239","BK0096","BK0028"],"gpt_icon":0},{"id":"2577372962","title":"金陵药业（000919）披露向特定对象发行股票部分限售股份解除限售上市流通提示性公告，10月23日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577372962","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577372962?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:42","pubTimestamp":1761212524,"startTime":"0","endTime":"0","summary":"公告显示，本次解除限售股份为2023年度向特定对象发行的股票，解除限售数量为31,446,541股，占公司总股本的5.0563%。本次解除限售股份可上市流通日期为2025年10月24日。本次解除限售股份持有人为公司控股股东南京新工投资集团有限责任公司，其认购的股份限售期为18个月。本次发行新增股份于2024年4月22日上市，总股本由511,113,600股增至629,060,528股。本次解除限售后，公司限售条件流通股由31,604,341股减少至157,800股，无限售条件流通股由590,320,187股增至621,766,728股，总股本不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300027680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","000919"],"gpt_icon":0},{"id":"2577830840","title":"金陵药业：截至2025年10月20日股东人数为35,009","url":"https://stock-news.laohu8.com/highlight/detail?id=2577830840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577830840?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:48","pubTimestamp":1761036490,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至10月20日的股东人数是多少？金陵药业回复：尊敬的投资者，您好！截至2025年10月20日，公司股东人数为35,009，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100024700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0096","BK0239"],"gpt_icon":0},{"id":"2575971993","title":"金陵药业（000919）披露限制性股票回购注销完成公告，10月16日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575971993","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575971993?lang=zh_cn&edition=full","pubTime":"2025-10-16 17:15","pubTimestamp":1760606132,"startTime":"0","endTime":"0","summary":"截至2025年10月16日收盘，金陵药业报收于6.98元，较前一交易日上涨0.14%，最新总市值为43.41亿元。该股当日开盘6.97元，最高7.02元，最低6.94元，成交额达5744.99万元，换手率为1.39%。公司近日发布公告称，已完成限制性股票回购注销工作。本次回购注销的股票数量为1,784,100股，涉及激励对象78人，占回购前总股本的0.29%。本次回购注销完成后，公司总股本由623,708,628股变更为621,924,528股。公告指出，本次回购注销不影响公司股权分布及上市地位，亦不损害股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101600026610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","000919","BK0028"],"gpt_icon":0},{"id":"2575262645","title":"金陵药业：截至2025年10月10日股东人数为34,733","url":"https://stock-news.laohu8.com/highlight/detail?id=2575262645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575262645?lang=zh_cn&edition=full","pubTime":"2025-10-14 16:30","pubTimestamp":1760430647,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止至2025年10月10日收盘公司股东人数为多少，谢谢金陵药业回复：尊敬的投资者，您好！截至2025年10月10日，公司股东人数为34,733，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400051913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0096","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766731144664,"stockEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.049},{"period":"3month","weight":0.0949},{"period":"6month","weight":0.1141},{"period":"1year","weight":0.1391},{"period":"ytd","weight":0.1565}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":0.0232},{"period":"3month","weight":0.0344},{"period":"6month","weight":0.1564},{"period":"1year","weight":0.1669},{"period":"ytd","weight":0.1814}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金陵药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"37395人(较上一季度增加14.05%)","perCapita":"16627股","listingDate":"1999-11-18","address":"江苏省南京市栖霞区经济技术开发区新港大道58号","registeredCapital":"62192万元","survey":" 金陵药业股份有限公司的主营业务是药品、医疗器械制造和医康养护服务。公司的主要产品是脉络宁注射液/口服液、琥珀酸亚铁片、香菇多糖注射液、吸收性明胶海绵等。“桂冠”商标为中国驰名商标，“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品，“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。","listedPrice":8.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金陵药业,000919,金陵药业股票,金陵药业股票老虎,金陵药业股票老虎国际,金陵药业行情,金陵药业股票行情,金陵药业股价,金陵药业股市,金陵药业股票价格,金陵药业股票交易,金陵药业股票购买,金陵药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}